Vimian Group Past Earnings Performance
Past criteria checks 4/6
Vimian Group's earnings have been declining at an average annual rate of -42.7%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 15.9% per year. Vimian Group's return on equity is 3.5%, and it has net margins of 5.6%.
Key information
-42.66%
Earnings growth rate
-106.69%
EPS growth rate
Medical Equipment Industry Growth | 6.16% |
Revenue growth rate | 15.85% |
Return on equity | 3.45% |
Net Margin | 5.64% |
Next Earnings Update | 22 Oct 2025 |
Recent past performance updates
Recent updates
If EPS Growth Is Important To You, Vimian Group (STO:VIMIAN) Presents An Opportunity
Jun 17Estimating The Intrinsic Value Of Vimian Group AB (publ) (STO:VIMIAN)
Jun 02Getting In Cheap On Vimian Group AB (publ) (STO:VIMIAN) Is Unlikely
May 15Is Vimian Group (STO:VIMIAN) A Risky Investment?
Mar 05Vimian Group's (STO:VIMIAN) Earnings Are Weaker Than They Seem
Feb 21A Look At The Fair Value Of Vimian Group AB (publ) (STO:VIMIAN)
Feb 14iM3 Acquisition Will Expand Presence In Veterinary Dental Space
Expansion in Specialty Pharma and strategic focus on cash generation are expected to drive organic growth, enhancing revenue and margins.Returns On Capital Are Showing Encouraging Signs At Vimian Group (STO:VIMIAN)
Dec 16Revenues Not Telling The Story For Vimian Group AB (publ) (STO:VIMIAN) After Shares Rise 27%
Aug 31Is Vimian Group (STO:VIMIAN) A Risky Investment?
Aug 17Vimian Group (STO:VIMIAN) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 18Vimian Group AB (publ) (STO:VIMIAN) Shares Could Be 40% Below Their Intrinsic Value Estimate
Apr 09Vimian Group (STO:VIMIAN) Is Experiencing Growth In Returns On Capital
Feb 13Little Excitement Around Vimian Group AB (publ)'s (STO:VIMIAN) Revenues
Jan 08Why Vimian Group AB (publ) (STO:VIMIAN) Could Be Worth Watching
Dec 03There's Been No Shortage Of Growth Recently For Vimian Group's (STO:VIMIAN) Returns On Capital
Nov 01Vimian Group AB (publ)'s (STO:VIMIAN) Intrinsic Value Is Potentially 92% Above Its Share Price
Aug 27When Should You Buy Vimian Group AB (publ) (STO:VIMIAN)?
Jul 19Are Investors Undervaluing Vimian Group AB (publ) (STO:VIMIAN) By 27%?
May 19Returns On Capital Are Showing Encouraging Signs At Vimian Group (STO:VIMIAN)
Apr 04Calculating The Intrinsic Value Of Vimian Group AB (publ) (STO:VIMIAN)
Jan 06Returns On Capital Are Showing Encouraging Signs At Vimian Group (STO:VIMIAN)
Dec 09Is Vimian Group AB (publ) (STO:VIMIAN) Trading At A 38% Discount?
Aug 25We Like These Underlying Return On Capital Trends At Vimian Group (STO:VIMIAN)
Jun 18Is Vimian Group AB (publ) (STO:VIMIAN) Trading At A 34% Discount?
May 19Revenue & Expenses Breakdown
How Vimian Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 25 | 404 | 23 | 190 | 0 |
31 Mar 25 | 391 | 19 | 181 | 0 |
31 Dec 24 | 375 | 19 | 174 | 0 |
30 Sep 24 | 352 | 0 | 172 | 0 |
30 Jun 24 | 345 | 10 | 165 | 0 |
31 Mar 24 | 335 | 8 | 162 | 0 |
31 Dec 23 | 332 | 10 | 154 | 0 |
30 Sep 23 | 325 | -5 | 141 | 0 |
30 Jun 23 | 316 | -14 | 140 | 0 |
31 Mar 23 | 301 | -7 | 134 | 0 |
31 Dec 22 | 281 | -7 | 128 | 0 |
30 Sep 22 | 255 | 16 | 117 | 0 |
30 Jun 22 | 225 | 17 | 104 | 0 |
31 Mar 22 | 198 | 4 | 96 | 0 |
31 Dec 21 | 173 | 7 | 84 | 0 |
30 Sep 21 | 153 | 58 | 72 | 0 |
30 Jun 21 | 132 | 58 | 58 | 0 |
31 Mar 21 | 104 | 60 | 41 | 0 |
31 Dec 20 | 71 | 53 | 29 | 0 |
31 Dec 19 | 25 | -1 | 12 | 0 |
31 Dec 18 | 8 | -1 | 4 | 0 |
Quality Earnings: VIMIAN has high quality earnings.
Growing Profit Margin: VIMIAN's current net profit margins (5.6%) are higher than last year (2.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VIMIAN's earnings have declined by 42.7% per year over the past 5 years.
Accelerating Growth: VIMIAN's earnings growth over the past year (132.6%) exceeds its 5-year average (-42.7% per year).
Earnings vs Industry: VIMIAN earnings growth over the past year (132.6%) exceeded the Medical Equipment industry -7.8%.
Return on Equity
High ROE: VIMIAN's Return on Equity (3.5%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/07/30 17:22 |
End of Day Share Price | 2025/07/30 00:00 |
Earnings | 2025/06/30 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Vimian Group AB (publ) is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
null null | ABG Sundal Collier |
Hassan Al-Wakeel | Barclays |
Blanka Porkolab | Barclays |